These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33838582)

  • 1. Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2.
    Attia GH; Moemen YS; Youns M; Ibrahim AM; Abdou R; El Raey MA
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111724. PubMed ID: 33838582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2.
    Wolfgruber S; Rieger J; Cardozo O; Punz B; Himly M; Stingl A; Farias PMA; Abuja PM; Zatloukal K
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential Pharmacological Mechanism of Hesperidin and Glucosyl Hesperidin against COVID-19 Based on Bioinformatics Analyses and Antiviral Assays.
    Huang Y; Zhou W; Sun J; Ou G; Zhong NS; Liu Z
    Am J Chin Med; 2022; 50(2):351-369. PubMed ID: 35232329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green Synthesized Zinc Oxide Nanoparticles Based on
    Alrabayah IN; Elhawary SS; Kandil ZA; El-Kadder EMA; Moemen YS; Saleh AM; El Raey MA
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hesperidin: A Potential Therapeutic Agent against COVID-19.
    Dhingra AK; Chopra B; Rathi V; Sapra S
    Curr Drug Discov Technol; 2023; 20(2):e171022210062. PubMed ID: 36263485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Efficacy of ZnO Nanostructures against SARS-CoV-2.
    Sportelli MC; Izzi M; Loconsole D; Sallustio A; Picca RA; Felici R; Chironna M; Cioffi N
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenic production of silver, zinc oxide, and cuprous oxide nanoparticles, and their impregnation into textiles with antiviral activity against SARS-CoV-2.
    Asmat-Campos D; Rojas-Jaimes J; de Oca-Vásquez GM; Nazario-Naveda R; Delfín-Narciso D; Juárez-Cortijo L; Bayona DE; Diringer B; Pereira R; Menezes DB
    Sci Rep; 2023 Jun; 13(1):9772. PubMed ID: 37328549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats.
    El-Fakharany EM; El-Gendi H; El-Maradny YA; Abu-Serie MM; Abdel-Wahhab KG; Shabana ME; Ashry M
    Int J Biol Macromol; 2023 Aug; 245():125552. PubMed ID: 37356684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hesperidin, a Potential Antiviral Agent against SARS-CoV-2: The Influence of Citrus Consumption on COVID-19 Incidence and Severity in China.
    Kowalczyk A
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine.
    Ghaffari H; Tavakoli A; Moradi A; Tabarraei A; Bokharaei-Salim F; Zahmatkeshan M; Farahmand M; Javanmard D; Kiani SJ; Esghaei M; Pirhajati-Mahabadi V; Monavari SH; Ataei-Pirkooh A
    J Biomed Sci; 2019 Sep; 26(1):70. PubMed ID: 31500628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary metabolites from spice and herbs as potential multitarget inhibitors of SARS-CoV-2 proteins.
    Gupta S; Singh V; Varadwaj PK; Chakravartty N; Katta AVSKM; Lekkala SP; Thomas G; Narasimhan S; Reddy AR; Reddy Lachagari VB
    J Biomol Struct Dyn; 2022 Mar; 40(5):2264-2283. PubMed ID: 33107812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of
    Hendi AA; Virk P; Awad MA; Elobeid M; Ortashi KMO; Alanazi MM; Alkallas FH; Almoneef MM; Abdou MA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
    Haggag YA; El-Ashmawy NE; Okasha KM
    Med Hypotheses; 2020 Nov; 144():109957. PubMed ID: 32531538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Application of Zinc Oxide Nanoparticles for Inhibition of
    Almansorri AK; Al-Shirifi HMH; Al-Musawi S; Ahmed BB
    Arch Razi Inst; 2023 Feb; 78(1):277-285. PubMed ID: 37312695
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection.
    Cheng FJ; Huynh TK; Yang CS; Hu DW; Shen YC; Tu CY; Wu YC; Tang CH; Huang WC; Chen Y; Ho CY
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
    Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of Silver Cations, Silver-Cystine Complexes, Ag Nanoclusters, and Nanoparticles towards SARS-CoV-2 RNA and Recombinant Virion Proteins.
    Morozova OV; Manuvera VA; Grishchechkin AE; Barinov NA; Shevlyagina NV; Zhukhovitsky VG; Lazarev VN; Klinov DV
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632644
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of Infectivity of SARS-CoV-2 by Zinc Oxide Coatings.
    Hosseini M; Behzadinasab S; Chin AWH; Poon LLM; Ducker WA
    ACS Biomater Sci Eng; 2021 Nov; 7(11):5022-5027. PubMed ID: 34613703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transparent Anti-SARS COV-2 Film from Copper(I) Oxide Incorporated in Zeolite Nanoparticles.
    Jampa S; Ratanatawanate C; Pimtong W; Aueviriyavit S; Chantho V; Sillapaprayoon S; Kunyanee C; Warin C; Gamonchuang J; Kumnorkaew P
    ACS Appl Mater Interfaces; 2022 Nov; 14(46):52334-52346. PubMed ID: 36352778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.